After retiring from the league he joined the industry.
It’s a new Era.
PAX Labs has created a new vaporizer, PAX Era, in partnership with the Lab, the concentrates production division of the Clinic. “It really is the first pen that’s true technology,” says Sunni Marsden, a representative from the Lab. “It’s next level, for sure.”
He held a hearing on how its classified by the Federal Government.
South Carolina Sen. Lindsey Graham is the latest high-profile Republication to show hints of evolving on cannabis policy. He’s a cosponsor of the CARERS Act which would, Politico writes: “reclassify marijuana so that it is considered to have some medical value; permit banks to handle money from legal marijuana businesses; prevent the government from interfering with state-legal medical marijuana programs; exclude non-psychoactive marijuana extracts from the definition of marijuana; grant military veterans access to medical marijuana; and break the government’s monopoly on medical marijuana research.”
Grammy-winning artist Damian “Jr. Gong” Marley has partnered up with TruCannabis to open a new dispensary in Denver on September 22.
“Damian Marley’s Stony Hill – by TruCannabis” is located at 1630 Federal Boulevard, adjacent to Mile High Stadium, and will replace TruCannabis’s flagship location.
Hundreds of cases may not go forward.
Some states are reducing the size of drug-free school zones, a policy that’s under new scrutiny. The State University of New York, one of the country’s largest systems, will stop asking applicants if they have a felony conviction.
The new company will be a major player in seeds and pharmaceuticals, two cannabis sweet spots.
In one of the largest mergers ever, the German chemical and pharamaceutical giant Bayer will buy seed company Monsanto for $66 billion. Mainstream reports did not bring it up, but both companies have long been seen as interested in the plant. (Bayer has a partnership with GW Pharmaceuticals.) In July, the far-left site Counterpunch published a piece called “ Monsanto, Bayer and the Push for Corporate Cannabis.”
At an L.A. conference, Viridian Capital Advisors president Scott Greiper said legalization will bring about the next industrial revolution.
Business school student Cameron Lehman writes about opening a dispensary with his plastic surgeon mom. U.C. Berkeley’s Haas business school is starting a speaker and case study series on the green rush.
Medical testing company Quest Diagnostics says the number of Americans testing positive for illegal drugs reached a decade high of 4%. Among “safety-sensitive” workers it was 1.8 %, a slight increase.
A new study found that states with legal, accessible MED saw decreases in opioid use in adults 21-40.
Reason asks “ What will control freaks ban next?” The answer appears to be the southeast Asian plant Kratom, which the DEA is adding to the list of schedule I drugs. Wired calls Kratom a promising treatmentfor opiate addition.
Dana-Farber Cancer Institute blogged on whether MED benefits cancer patients.
Food Safety News picked up a Leafly story about how to know if weed is past its sell-by date.
Yes, tourists are coming to Colorado for the weed — but just not as many as you might think. In fact, according to a state-subsidized survey, only 12 percent of visitors to this state visit a dispensary.
Although tourism boosters shied away from discussing marijuana right after recreational use was legalized, pot was the focus of a panel yesterday morning at the Colorado Governor’s Tourism Conference in Beaver Creek. During “The Marijuana Message,” two experts spoke to an audience of about fifty tourism representatives from around the state about how many tourists are using cannabis, and how the state is working to educate them when they visit.
It received the British equivalent of bipartisan support.
In the U.K., a group representing MPs and Peers from concluded that banning MED is “ irrational.” It is being touted as a major step towards legalization.
Cannabis is an issue in Berlin’s upcoming election.
Vermont’s legislature is revisiting REC after failing to pass it last year. Arkansas Gov. and former DEA chief Asa Hutchinson (R) criticized supporters of the state’s upcoming MED votes for misleading the public about the plant’s medical benefits.
Denver Startup Week began in September 2012 as a chance for entrepreneurs to meet and trade ideas. Over the past five years, it’s evolved into an expansive event where anyone hoping to start a business can choose from hundreds of panel presentations featuring people who’ve been there, done that. And this year, ganjapreneurs are among the industry leaders sharing experiences and expertise.
At a September 13 panel titled “From Kitchen to ‘Shelf:’ Smart Growth Tips for Packaged Food Startups” at the Infinite Monkey Theorem Urban Winery, Andrew Schrot, founder and CEO of BlueKudu, a prominent edibles company, joined food-industry reps from 34 Degrees, Saso Pepper Co. and Capello’s Gluten Free; BrandJuice creative director John Bellina moderated a discussion that focused on the ever-growing food market in Colorado.
It currently sells a powerful opiate.
Here’s your daily round-up of pot-news, excerpted from the newsletter WeedWeek.
The Intercept reports that Insys Therapeutics, the company that donated $500,000 to oppose REC in Arizona, is about to release a synthetic THC spray to relieve side effects associated with chemotherapy that would compete directly with MED. It’s been more widely noted that Insys’ only current product is an opioid spray. Insys noted in a 2007 SEC filing that legalization is a threat to its business.
Forbes surveys a list of cannabis-involved pharmaceutical companies that are takeover targets. Insys is among them.